Skip to main content

Data in later lines

References: 1. Scemblix. Prescribing information. Novartis Pharmaceuticals Corp. 2. Data on file. CABL001A2301 clinical study report (Week 156 analysis). Novartis Pharmaceuticals Corp; 2022. 3. Réa D, Mauro M, Boquimpani C, et al. Blood. 2021;138(21):2031-2041. 4. Réa D, Mauro M, Boquimpani C, et al. Blood. 2021;138(21)(suppl):1-37. 5. Data on file. CABL001A 96 Week SCS. Novartis Pharmaceuticals Corp; 2022. 6. Data on file. ABL001 SCS Appendix 8. Novartis Pharmaceuticals Corp; 2023.